31 – 40 of 81
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- Contribution to journal › Article
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
- Contribution to journal › Article
- 2012
-
Mark
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.
- Contribution to journal › Article
-
Mark
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer
- Contribution to journal › Article
-
Mark
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
- Contribution to journal › Article
-
Mark
A model for combinatorial regulation of the petunia R2R3-MYB transcription factor ODORANT1
- Contribution to journal › Article
-
Mark
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
- Contribution to journal › Article
- 2011
-
Mark
A dose-dependent role for EBF1 in repressing non-B-cell-specific genes
- Contribution to journal › Article
-
Mark
Densely interconnected transcriptional circuits control cell states in human hematopoiesis
- Contribution to journal › Article
-
Mark
The transcription factor EMISSION OF BENZENOIDS II activates the MYB ODORANT1 promoter at a MYB binding site specific for fragrant petunias
- Contribution to journal › Article
